Pre‐operative dexmedetomidine nasal spray and emergence agitation in adults undergoing ear, nose and throat surgery: a randomised controlled trial
Anaesthesia · 2025
DOI: 10.1111/anae.16726 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anaesthesia, 2025. Verfasst von Dan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Hypnotics and Sedatives, Emergence Delirium, Otorhinolaryngologic Surgical Procedures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Suzhou Basic Research Pilot Project, Suzhou Medical Health Science and Technology Innovation Project.
Abstract (Originalsprache)
Introduction
Emergence agitation is common after ear, nose and throat surgery, causing patient discomfort and increased risk of complications. We hypothesised that pre‐operative dexmedetomidine nasal spray would reduce the incidence of emergence agitation in adult patients undergoing these procedures.
Methods
We conducted a randomised double‐blind controlled trial in adults scheduled for ear, nose and throat surgery. Patients were allocated (1:1) to receive nasal spray with dexmedetomidine (75–100 μg based on age and weight) or 0.9% saline, 30 min before induction. Sevoflurane anaesthesia was titrated to bispectral index 40–60. The primary outcome was the incidence of emergence agitation (Riker sedation agitation scale score ≥ 5 from sevoflurane discontinuation to 5 min post‐tracheal extubation).
Results
We recruited 159 patients (median (IQR [range]) age 50 (36–60 [18–77]) y; 62% male). The incidence of emergence agitation in patients allocated to the dexmedetomidine group was 25% (20/80) compared with 47% (37/79) in those allocated to the 0.9% saline group (RR 0.53, 95%CI 0.34–0.82, p = 0.004), with a number needed to treat of 4.6. Secondary and exploratory outcomes showed that dexmedetomidine nasal spray was associated with: less venepuncture pain; reduced rate of sleep disturbance on the first night after surgery; and higher patient satisfaction, without increasing adverse events.
Discussion
Pre‐operative dexmedetomidine nasal spray reduced emergence agitation in adult patients undergoing ear, nose and throat surgery, and could enhance peri‐operative care for these procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, China.
- Department of Anaesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA, USA.
ORCID-Profile: Ke Peng
Förderung
- National Natural Science Foundation of China
- Suzhou Basic Research Pilot Project
- Suzhou Medical Health Science and Technology Innovation Project
- Suzhou Key Laboratory of Anesthesiology
Zitieren
APA
Wang, D., Dou, W., Hu, J. H., Huang, L., Liu, H., Ji, F. H., & Peng, K. (2025). Pre‐operative dexmedetomidine nasal spray and emergence agitation in adults undergoing ear, nose and throat surgery: a randomised controlled trial. Anaesthesia. https://doi.org/10.1111/anae.16726
Vancouver
Wang D, Dou W, Hu JH, Huang L, Liu H, Ji FH, et al. Pre‐operative dexmedetomidine nasal spray and emergence agitation in adults undergoing ear, nose and throat surgery: a randomised controlled trial. Anaesthesia. 2025. doi:10.1111/anae.16726
BibTeX
@article{Wang2025,
author = {Wang, Dan and Dou, Wei and Hu, Jing-Hui and Huang, Lei and Liu, Hong and Ji, Fu-Hai and Peng, Ke},
title = {Pre‐operative dexmedetomidine nasal spray and emergence agitation in adults undergoing ear, nose and throat surgery: a randomised controlled trial},
journal = {Anaesthesia},
year = {2025},
doi = {10.1111/anae.16726}
}
EUVIMED